The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global spinal implants and surgery devices market reached a value of US$ 10.1 Billion in 2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Spinal implants and surgery devices refer to the medical equipment used to treat spinal deformities and disorders. These implants are manufactured using biocompatible materials, such as titanium, titanium-alloy and stainless-steel, and are commonly available in two variants, namely fusion and non-fusion implants. Fusion implants include rods, plates, screws and interbody cages. On the other hand, non-fusion implants include artificial discs, expandable rods and growth sparing devices. Apart from this, thoracic, lumbar and cervical fusion and spinal decompression devices are also used for various treatment procedures. These implants are used to facilitate the movement of two vertebrae, improve the stability of the spine and correct deformities.
The increasing prevalence of spinal disorders, such as degenerative disc disease, scoliosis, kyphosis and spondylolisthesis, is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the majority of the working population, which, in turn, is significantly increasing the incidences of obesity, back pain, posture-related problems and other degenerative spinal conditions. Furthermore, the development of efficient growth-sparing devices, which are specifically designed for patients, especially children, who have not reached skeletal maturity is also contributing to the market growth. Additionally, various technological advancements, such as the development of advanced bone grafting products and the utilization of materials that are more durable than metal, are favoring the growth of the market. Other factors, including the rising geriatric population and widespread adoption of minimally invasive (MI) spinal surgeries, are expected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global spinal implants and surgery devices market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, type of surgery and end user.
Breakup by Product:
Breakup by Type of Surgery:
Breakup by End User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, B. Braun (B. Braun Holding GmbH & Co. KG), Boston Scientific, Depuy Synthes (Johnson & Johnson), Exactech Inc. (Choice Spine), Globus Medical Inc., Integra LifeSciences Holdings Corporation, Medtronic Plc, Nuvasive Inc. (Smith & Nephew Plc), Orthofix Medical Inc., RTI Surgical Inc., Stryker Corporation and Zimmer Biomet Holdings Inc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Type of Surgery, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, B. Braun (B. Braun Holding GmbH & Co. KG), Boston Scientific, Depuy Synthes (Johnson & Johnson), Exactech Inc. (Choice Spine), Globus Medical Inc., Integra LifeSciences Holdings Corporation, Medtronic Plc, Nuvasive Inc. (Smith & Nephew Plc), Orthofix Medical Inc., RTI Surgical Inc., Stryker Corporation and Zimmer Biomet Holdings Inc|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at